WEST PHARMACEUTICAL SERVICES INC - 8-K Filing
West Pharmaceutical Services announced that Michel Lagarde will become President and CEO effective August 31, 2026. Eric Green is retiring from the roles of CEO and Chair after ensuring a transition period. Under his employment agreement, Lagarde receives an annual base salary of $1.175 million, target incentive awards up to $1.469 million annually, and long-term incentives with a total grant value of $8.61 million for 2026. (Items: 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Offi, 7.01 Regulation FD Disclosure, 9.01 Financial Statements and Exhibits)
Tickers: $WST